Neuroleptic malignant syndrome after addition of paroxetine to olanzapine

J Clin Psychopharmacol. 2003 Dec;23(6):671-2. doi: 10.1097/01.jcp.0000096245.29231.a8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Benzodiazepines / administration & dosage
  • Benzodiazepines / adverse effects*
  • Drug Therapy, Combination
  • Female
  • Humans
  • Middle Aged
  • Neuroleptic Malignant Syndrome / etiology*
  • Olanzapine
  • Paroxetine / administration & dosage
  • Paroxetine / adverse effects*
  • Selective Serotonin Reuptake Inhibitors / administration & dosage
  • Selective Serotonin Reuptake Inhibitors / adverse effects*

Substances

  • Serotonin Uptake Inhibitors
  • Benzodiazepines
  • Paroxetine
  • Olanzapine